1. Home
  2. CRVS vs RXT Comparison

CRVS vs RXT Comparison

Compare CRVS & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVS
  • RXT
  • Stock Information
  • Founded
  • CRVS 2014
  • RXT 1998
  • Country
  • CRVS United States
  • RXT United States
  • Employees
  • CRVS N/A
  • RXT N/A
  • Industry
  • CRVS Biotechnology: Pharmaceutical Preparations
  • RXT EDP Services
  • Sector
  • CRVS Health Care
  • RXT Technology
  • Exchange
  • CRVS Nasdaq
  • RXT Nasdaq
  • Market Cap
  • CRVS 305.4M
  • RXT 322.8M
  • IPO Year
  • CRVS 2016
  • RXT 2020
  • Fundamental
  • Price
  • CRVS $4.03
  • RXT $1.35
  • Analyst Decision
  • CRVS Strong Buy
  • RXT Hold
  • Analyst Count
  • CRVS 4
  • RXT 4
  • Target Price
  • CRVS $15.00
  • RXT $1.63
  • AVG Volume (30 Days)
  • CRVS 1.2M
  • RXT 1.2M
  • Earning Date
  • CRVS 08-05-2025
  • RXT 08-07-2025
  • Dividend Yield
  • CRVS N/A
  • RXT N/A
  • EPS Growth
  • CRVS N/A
  • RXT N/A
  • EPS
  • CRVS N/A
  • RXT N/A
  • Revenue
  • CRVS N/A
  • RXT $2,711,700,000.00
  • Revenue This Year
  • CRVS N/A
  • RXT N/A
  • Revenue Next Year
  • CRVS N/A
  • RXT $1.48
  • P/E Ratio
  • CRVS N/A
  • RXT N/A
  • Revenue Growth
  • CRVS N/A
  • RXT N/A
  • 52 Week Low
  • CRVS $1.75
  • RXT $1.00
  • 52 Week High
  • CRVS $10.00
  • RXT $3.41
  • Technical
  • Relative Strength Index (RSI)
  • CRVS 50.43
  • RXT 59.20
  • Support Level
  • CRVS $3.55
  • RXT $1.25
  • Resistance Level
  • CRVS $4.09
  • RXT $1.38
  • Average True Range (ATR)
  • CRVS 0.31
  • RXT 0.08
  • MACD
  • CRVS -0.03
  • RXT 0.01
  • Stochastic Oscillator
  • CRVS 49.14
  • RXT 84.62

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: